ONWD — Onward Medical NV Income Statement
0.000.00%
Last trade - 00:00- €179.25m
- €164.51m
- €0.07m
Annual income statement for Onward Medical NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0.104 | 0.068 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10.8 | 15.5 | 28.5 | 32.1 | 35.5 |
| Operating Profit | -10.8 | -15.5 | -28.5 | -32 | -35.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.4 | -20 | -34.2 | -33.5 | -36.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13.5 | -20 | -34.3 | -32.8 | -36.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -13.5 | -20 | -34.3 | -32.8 | -36.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -13.5 | -20 | -34.3 | -32.8 | -36.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.452 | -0.672 | -3.62 | -1.09 | -1.2 |